Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2007

Authors

  • Glenda L Lawrence National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. University of Sydney and The Children’s Hospital at Westmead, Sydney
  • Padmasiri E Aratchige National Centre for Immunisation Research and Surveillance of Vaccine Preventable Diseases. University of Sydney and The Children’s Hospital at Westmead, Sydney
  • Richard Hill Therapeutic Goods Administration, Symonston, Australian Capital Territory

DOI:

https://doi.org/10.33321/cdi.2007.31.40

Keywords:

AEFI, surveillance, immunisation, vaccine safety

Abstract

This report summarises national passive surveillance data for adverse events following immunisation (AEFI) reported for children aged less than 7 years who received vaccines between 1 January and 30 June 2007, and supplements the AEFI annual report.

Downloads

Download data is not yet available.

References

Australian Government Department of Health and Ageing. Immunisation programs and initiatives. Available from: http://immunise.health.gov.au/internet/immunise/publishing.nsf/Content/programs Accessed November 2007..

National Health and Medical Research Council. The Australian Immunisation Handbook. 8th ed. Canberra: Australian Government Publishing Service; 2003.

P Toyne, Minister for Health. Territory to fund rotavirus vaccine. Media release, Northern Territory Government; 23 August 2006. Available from: http://newsroom.nt.gov.au/index.cfm?fuseaction=viewRelease&id=287&d=5 Accessed November 2007.

National Centre for Immunisation Research and Surveillance. Rotavirus vaccines for Australian children: Information for GPs and immunisation providers. Available from: http://www.ncirs.usyd.edu.au/facts/rotavirus_vaccine_for_children_june_2007.pdf Accessed November 2007.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, et al. Surveillance of adverse events following immunisation: Australia, 2000–2002. Commun Dis Intell 2003; 27:307–323.

Lawrence G, Boyd I. Supplementary report: surveillance of adverse events following immunisation among children aged < 7 years in Australia, 1 January to 30 June 2006. Commun Dis Intell 2006; 30:438–442.

Lawrence GL, Aratchige PE, Boyd I, McIntyre PB, Gold MS. Annual report on surveillance of adverse events following immunisation in Australia, 2006. Commun Dis Intell 2007; 31:269–282.

Lawrence G, Boyd I. Supplementary report: surveillance of adverse events following immunisation among children aged less than 7 years in Australia, 1 January to 30 June 2005. Commun Dis Intell 2005; 29(4):413–416.

Gold MS, Noonan S, Osbourn M, Precepa S, Kempe AE. Local reactions after the fourth-dose of acellular pertussis vaccine in South Australia. Med J Aust 2003;179:191–194.

Lawrence G, Boyd I. Surveillance of adverse events following immunisation for children aged less than 7 years, 1 January to 30 June 2004. Commun Dis Intell 2004;28:490–492.

Downloads

Published

01/12/07

How to Cite

Lawrence, Glenda L, Padmasiri E Aratchige, and Richard Hill. 2007. “Supplementary Report: Surveillance of Adverse Events Following Immunisation Among Children Aged Less Than 7 Years in Australia, 1 January to 30 June 2007”. Communicable Diseases Intelligence 31 (December):379-82. https://doi.org/10.33321/cdi.2007.31.40.

Issue

Vol. 31 (2007)

Section

Surveillance summary

Categories

License

Copyright (c) 2007 Communicable Diseases Intelligence

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.

Most read articles by the same author(s)